ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676591 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676591; 2) Community: the network communities that were significantly associated with the response to NSC 676591; 3) Molecule: the relationships between components within communities and NSC 676591; 4) MDR: the compounds that were significantly associated with the NSC 676591.

NSC Compound Enrichment Correlation
NSC 748900 [(20S)-20-(N,N-dimethylamino)-3a-(tigloylamino)-5a-preg-2a -O-acetate-4a-ol] 0.0181211508101519 0.14335116
NSC 764037 BP-1-102 0.0181211508101519 0.45716415
NSC 92915 ANTINEOPLASTIC-92915 0.0181211508101519 0.50062943
NSC 9598 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride 0.0181211508101519 0.2601132
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0187206825450445 0.62723447
NSC 65346 Antibiotic from Streptomyces 0.0187206825450445 0.22741223
NSC 698088 Null 0.0187206825450445 0.20493553
NSC 76919 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- 0.0187206825450445 0.1160273
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0208632511155816 0.39377223
NSC 13484 Null 0.0208632511155816 0.35680989
Total:100  Current:48    [First] [Prev] [Next] [Last]